Alternative Data for ANI Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 18 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 12,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 94 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 18 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,135 | Sign up | Sign up | Sign up |
| X Mentions | 36 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 60 | Sign up | Sign up | Sign up |
| Linkedin Employees | 636 | Sign up | Sign up | Sign up |
About ANI Pharmaceuticals
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.
| Price | $82.10 |
| Target Price | Sign up |
| Volume | 256,710 |
| Market Cap | $1.89B |
| Year Range | $57.27 - $98.81 |
| Dividend Yield | 0% |
| PE Ratio | 52.72 |
| Analyst Rating | 75% buy |
| Industry | Biotechnology |
In the news
 |
Here's How ANIP's Rare Disease Portfolio Is Driving Top-line GrowthNovember 20 - Yahoo |
 |
ANIP Q3 Deep Dive: Rare Disease Momentum and Generics Expansion Drive Upgraded OutlookNovember 7 - Yahoo Entertainment |
 |
ANI Pharmaceuticals, Inc. (ANIP) Q3 2025 Earnings Call TranscriptNovember 6 - SeekingAlpha |
|
ANI Pharmaceuticals (ANIP): Evaluating Valuation After Strong 2024 Share Price GainsNovember 2 - Yahoo |
|
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseOctober 31 - Yahoo |
 |
ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating EstimatesOctober 28 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 228M | 116M | 112M | 24M | 61M | 2.040 |
| Q2 '25 | 211M | 75M | 137M | 8.5M | 39M | 1.800 |
| Q1 '25 | 197M | 73M | 124M | 16M | 48M | 0.690 |
| Q4 '24 | 191M | 80M | 110M | -10M | 15M | -0.550 |
| Q3 '24 | 148M | 63M | 85M | -24M | -13M | 1.340 |
Insider Transactions View All
| Davis Krista filed to sell 58,564 shares at $82.4. December 19 '25 |
| Cook Meredith filed to sell 74,874 shares at $82.3. December 12 '25 |
| TANNENBAUM RENEE P filed to sell 25,157 shares at $81.2. December 9 '25 |
| Gassert Chad filed to sell 158,490 shares at $88. November 14 '25 |
| Cook Meredith filed to sell 75,274 shares at $87.3. November 14 '25 |
Similar companies
Read more about ANI Pharmaceuticals (ANIP) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of ANI Pharmaceuticals?
The Market Cap of ANI Pharmaceuticals is $1.89B.
What is ANI Pharmaceuticals' PE Ratio?
As of today, ANI Pharmaceuticals' PE (Price to Earnings) ratio is 52.72.
What is the current stock price of ANI Pharmaceuticals?
Currently, the price of one share of ANI Pharmaceuticals stock is $82.10.
How can I analyze the ANIP stock price chart for investment decisions?
The ANIP stock price chart above provides a comprehensive visual representation of ANI Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ANI Pharmaceuticals shares. Our platform offers an up-to-date ANIP stock price chart, along with technical data analysis and alternative data insights.
Does ANIP offer dividends to its shareholders?
As of our latest update, ANI Pharmaceuticals (ANIP) does not offer dividends to its shareholders. Investors interested in ANI Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ANI Pharmaceuticals?
Some of the similar stocks of ANI Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.
